Anwar, S., Peters, O., Millership, S., Ninkina, N., Doig, N., Connor-Robson, N., Threlfell, S., Kooner, G., Bolam, J.P., Chandra, S., Deacon, R., Bannerman, D., Cragg, S.J.*, Wade-Martins, R.* and Buchman, V.L.* (2011) Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. In press, Journal of Neuroscience.

Gimenez-Cassina, A.^‡, Wade-Martins, R.^‡, Gomez-Sebastian, S., Corona, J.-C., Lim, F. and Diaz-Nido, J. (2011) Infectious delivery and long-term persistence of transgene expression in the brain by a 135 kb iBAC-FRDA genomic DNA expression vector. In press, Gene Therapy.

Shipton, O.A. Leitz, J.R. Dworzak, J., Acton, C.E.J., Denk, F., Dawson, H.N., Vitek, M.P., Wade-Martins, R., Paulsen, O. and Vargas-Caballero, M. (2011) Tau protein is required for amyloid b-induced impairment of hippocampal long-term potentiation. Journal of Neuroscience 31(5):1688-1692.

Lourenco-Venda, L., Cragg, S.J., Buchman, V.L. and Wade-Martins, R.* (2010) Alpha-synuclein and dopamine at the crossroads of Parkinson's disease; Trends in Neurosciences 33(12):559-68.

Hibbitt O.C., McNeil E., Lufino M.M., Seymour L., Channon K.M., and Wade-Martins R.* (2010) Long-term Physiologically Regulated Expression of the Low-density Lipoprotein Receptor In Vivo Using Genomic DNA Mini-gene Constructs. Molecular Therapy 18(2):317-26.